Cure My Disease

Don't miss your cure!

 Log in / Sign up

New gel stops bleeding during spine surgery

NCT ID NCT07354178

Disease control Sponsor: DALIM TISSEN Co., Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new gel-like product that helps stop bleeding during spinal surgery. It was compared to an existing product in 130 patients with spinal stenosis, tumors, or injuries. The goal was to see if the new product works just as well and is safe to use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

130 people

The number who actually took part.

Started

Oct 2024

Finished

Aug 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. An individual who has voluntarily signed the written consent form for participating in the research as a trial subject 2. Patients aged 20 or older 3. Patients who are able to participate throughout the entire clinical trial period 4. Patient scheduled to have spinal surgery due to spinal stenosis, spinal tumor, injury, etc. 5. Patients for whom hemostasis is difficult to achieve using standard procedures 6. Patients with grade 3 or higher bleeding \* Grade 4 or 5 bleeding is reduced to grade 3 by normal procedures (compression, sutures, electrosurgical scalpel, etc.). Exclusion Criteria: 1. Pregnant women or those planning to become pregnant within 1 month after application of the collagen-based hemostat 2. Individuals with hypersensitivity to bovine-, porcine-, or animal-derived materials 3. Individuals deemed inappropriate for participation by the investigators 4. Patients who are using treatments that may affect the test results 5. Patients with active infections at the surgical site 6. Patients with contraindications to the use of local hemostatic materials

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemostasis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Blood Loss, Surgical spinal cord cancer spinal cord neoplasm spinal injury spinal stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemostasis Intraoperative bleeding Spinal injury Spinal stenosis Spinal surgery Spinal tumor

Contacts and locations

Locations

  • Gangnam Severance Hospital

    Seoul, Gangnam-gu, 06273, South Korea

  • Severance Hospital, Yonsei University Health Syetem

    Seoul, Seodaemun-gu, 03722, South Korea

  • Yongin Severance Hospital

    Yongin-si, Giheung-gu, 16995, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.